This section is dedicated to recommendations around adverse events resulting from blood component / product transfusion, including recalling samples based on post-donation recipient information and the adverse event reporting pathway.
Copy citation
Prokopchuk-Gauk O, Tinmouth A, Rajappannair L, Whitman L, et al. Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada - Supplement: Contacts for National ATR Report Recipients and Provincial TTISS Personnel [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; April 5, 2024 [cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/overview-adverse-transfusion-reaction-reporting-hospitals-canada-supplement-contacts
Copy citation
Prokopchuk-Gauk O, Tinmouth A, Rajappannair L, Whitman L, et al. Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada: A NAC and CCNMT Collaborative Initiative [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; April 5, 2024 [cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/overview-adverse-transfusion-reaction-reporting-hospitals-canada-nac-and-quebec
Copy citation
Petraszko T, Tinmouth A, Tran A, Rajappannair L, Liwski R, Laureano M, et al. Recommendations for the Notification of Recipients of a Blood Component Recall: a NAC and CBS Collaborative Initiative [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; July 14, 2015 [updated 2023 07 20; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/recommendations-notification-recipients-blood-component-recall